SCHEMBL9497903

SCHEMBL9497903

CC(C)(CO[N+](=O)[O-])C(=O)NCCN1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
BCHE P06276 2/20 0.41
ACHE P22303 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
DRD2 P14416 4/20 0.40
DRD4 P21917 4/20 0.40
HTR1A P08908 2/20 0.40
KCNH2 Q12809 2/20 0.40
POLB P06746 2/20 0.37
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
PRMT8 Q9NR22 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9499554 0.99 BCHE (0.42) NPC1CA12CA1CA2CA9
SCHEMBL9497954 0.87 LMNA (0.49) MEN1KMT2AALDH1A1POLB
SCHEMBL9497614 0.81 ALDH1A1 (0.44) NPC1CA12CA1CA2CA9
SCHEMBL9345115 0.78 L3MBTL1 (0.41) BCHEACHEALDH1A1KDM4E
SCHEMBL9499223 0.76 ALDH1A1 (0.41) NPC1CA12CA1CA2CA9
SCHEMBL9500160 0.76 BCHE (0.41) BCHEACHEALDH1A1KDM4E
SCHEMBL21017768 0.75 DRD2 (0.59) NPC1CA12CA1CA2CA9
SCHEMBL8135888 0.75 DRD4 (0.55) NPC1CA12CA1CA2CA9
SCHEMBL9498052 0.73 BCHE (0.44) BCHEACHEMEN1KMT2AALDH1A1
SCHEMBL9498409 0.73 BCHE (0.40) CA12CA1CA2CA9BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0367019-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING NITROXYALKYL AMINE WITH AN AMIDE FUNCTION, AND METHOD FOR THE PREPARATION OF THE COMPOUNDS Roche Diagnostics GmbH (DE) 1993-05-12 EP disclosed
US-5037849-A For treatment of heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1991-08-06 US disclosed